
Tianjin Medical Journal ›› 2024, Vol. 52 ›› Issue (8): 845-849.doi: 10.11958/20231766
• Clinical Research • Previous Articles Next Articles
GUO Zhenjiang(
), ZHAO Guangyuan, DU Liqiang, LIU Fangzhen△(
)
Received:2023-11-27
Revised:2024-01-17
Published:2024-08-15
Online:2024-08-16
Contact:
E-mail:GUO Zhenjiang, ZHAO Guangyuan, DU Liqiang, LIU Fangzhen. Development and validation of a preoperative nomogram predictive model for proximal gastric cancer with microscopic positive margin[J]. Tianjin Medical Journal, 2024, 52(8): 845-849.
CLC Number:
| 变量 | 上切缘R1组 (n=15) | 上切缘R0组 (n=172) | Z或χ2 |
|---|---|---|---|
| 年龄/岁 | 65.6(59.0,72.8) | 65.3(56.0,74.0) | 0.144 |
| 性别 | |||
| 男 | 10(66.7) | 103(59.9) | 0.265 |
| 女 | 5(33.3) | 69(40.1) | |
| 肿瘤长度 | |||
| ≤4.85 cm | 5(33.3) | 116(67.4) | 7.028** |
| >4.85 cm | 10(66.7) | 56(32.6) | |
| 肿瘤位置 | |||
| 非EGJ癌 | 10(66.7) | 149(86.6) | 4.318* |
| EGJ癌 | 5(33.3) | 23(13.4) | |
| Borrmann分型 | |||
| Ⅰ—Ⅱ | 3(20.0) | 82(47.7) | 4.262* |
| Ⅲ—Ⅳ | 12(80.0) | 90(52.3) | |
| 肿瘤分化 | |||
| 高-中分化 | 3(20.0) | 53(30.8) | 0.769 |
| 低-未分化 | 12(80.0) | 119(69.2) | |
| Lauren分型 | |||
| 肠型 | 5(33.3) | 108(62.8) | 5.007* |
| 弥漫型/混合型 | 10(66.7) | 64(37.2) | |
| cT分期 | |||
| cT2—3 | 6(40.0) | 119(69.1) | 5.303* |
| cT4 | 9(60.0) | 53(30.9) | |
| cN分期 | |||
| cN0 | 7(46.7) | 124(70.1) | 4.252* |
| cN+ | 8(53.3) | 48(29.9) |
Tab.1 Univariate analysis of preoperative variables with positive upper margin of proximal gastric cancer
| 变量 | 上切缘R1组 (n=15) | 上切缘R0组 (n=172) | Z或χ2 |
|---|---|---|---|
| 年龄/岁 | 65.6(59.0,72.8) | 65.3(56.0,74.0) | 0.144 |
| 性别 | |||
| 男 | 10(66.7) | 103(59.9) | 0.265 |
| 女 | 5(33.3) | 69(40.1) | |
| 肿瘤长度 | |||
| ≤4.85 cm | 5(33.3) | 116(67.4) | 7.028** |
| >4.85 cm | 10(66.7) | 56(32.6) | |
| 肿瘤位置 | |||
| 非EGJ癌 | 10(66.7) | 149(86.6) | 4.318* |
| EGJ癌 | 5(33.3) | 23(13.4) | |
| Borrmann分型 | |||
| Ⅰ—Ⅱ | 3(20.0) | 82(47.7) | 4.262* |
| Ⅲ—Ⅳ | 12(80.0) | 90(52.3) | |
| 肿瘤分化 | |||
| 高-中分化 | 3(20.0) | 53(30.8) | 0.769 |
| 低-未分化 | 12(80.0) | 119(69.2) | |
| Lauren分型 | |||
| 肠型 | 5(33.3) | 108(62.8) | 5.007* |
| 弥漫型/混合型 | 10(66.7) | 64(37.2) | |
| cT分期 | |||
| cT2—3 | 6(40.0) | 119(69.1) | 5.303* |
| cT4 | 9(60.0) | 53(30.9) | |
| cN分期 | |||
| cN0 | 7(46.7) | 124(70.1) | 4.252* |
| cN+ | 8(53.3) | 48(29.9) |
| 变量 | 变量类型 | 变量赋值 |
|---|---|---|
| 上切缘状态 | 因变量 | R0=0,R1=1 |
| 肿瘤长度 | 自变量 | ≤4.85 cm=0,>4.85 cm=1 |
| 肿瘤位置 | 自变量 | 非EGJ癌=0,EGJ癌=1 |
| Borrmann分型 | 自变量 | Ⅰ—Ⅱ型=0,Ⅲ—Ⅳ型=1 |
| Lauren分型 | 自变量 | 肠型=0,弥漫型/混合型=1 |
| cT分期 | 自变量 | cT2—3期=0,cT4期=1 |
| cN分期 | 自变量 | cN0期=0,cN+期=1 |
Tab.2 Variable assignment table
| 变量 | 变量类型 | 变量赋值 |
|---|---|---|
| 上切缘状态 | 因变量 | R0=0,R1=1 |
| 肿瘤长度 | 自变量 | ≤4.85 cm=0,>4.85 cm=1 |
| 肿瘤位置 | 自变量 | 非EGJ癌=0,EGJ癌=1 |
| Borrmann分型 | 自变量 | Ⅰ—Ⅱ型=0,Ⅲ—Ⅳ型=1 |
| Lauren分型 | 自变量 | 肠型=0,弥漫型/混合型=1 |
| cT分期 | 自变量 | cT2—3期=0,cT4期=1 |
| cN分期 | 自变量 | cN0期=0,cN+期=1 |
| 变量 | β | SE | Wald χ2 | P | OR(95%CI) |
|---|---|---|---|---|---|
| 肿瘤长度 | 1.386 | 0.688 | 4.063 | 0.044 | 4.000(1.039~15.399) |
| 肿瘤位置 | 1.961 | 0.760 | 6.667 | 0.010 | 7.108(1.604~31.494) |
| Borrmann分型 | 1.945 | 0.773 | 6.334 | 0.012 | 6.991(1.538~31.782) |
| Lauren分型 | 2.026 | 0.730 | 7.706 | 0.006 | 7.583(1.814~31.701) |
| cT分期 | 2.110 | 0.752 | 7.876 | 0.005 | 8.249(1.890~36.007) |
| 常数项 | -6.895 | 1.262 | 29.830 | <0.001 | 0.001 |
Tab.3 Multivariate analysis of preoperative variables with positive uppermargin of proximal gastric cancer
| 变量 | β | SE | Wald χ2 | P | OR(95%CI) |
|---|---|---|---|---|---|
| 肿瘤长度 | 1.386 | 0.688 | 4.063 | 0.044 | 4.000(1.039~15.399) |
| 肿瘤位置 | 1.961 | 0.760 | 6.667 | 0.010 | 7.108(1.604~31.494) |
| Borrmann分型 | 1.945 | 0.773 | 6.334 | 0.012 | 6.991(1.538~31.782) |
| Lauren分型 | 2.026 | 0.730 | 7.706 | 0.006 | 7.583(1.814~31.701) |
| cT分期 | 2.110 | 0.752 | 7.876 | 0.005 | 8.249(1.890~36.007) |
| 常数项 | -6.895 | 1.262 | 29.830 | <0.001 | 0.001 |
| [1] | RAWLA P, BARSOUK A. Epidemiology of gastric cancer:global trends,risk factors and prevention[J]. Prz Gastroenterol, 2019, 14(1):26-38. doi:10.5114/pg.2018.80001. |
| [2] | 马岩, 薛英威. 胃上部癌手术消化道重建方式的选择[J]. 中华胃肠外科杂志, 2022, 25(5):396-400. |
| MA Y, XUE Y W. Choice of digestive tract reconstruction in upper gastric cancer[J]. Chin J Gastrointest Surg, 2022, 25(5):396-400. doi:10.3760/cma.j.cn441530-20220308-00092. | |
| [3] | KUMAZU Y, HAYASHI T, YOSHIKAWA T, et al. Risk factors analysis and stratification for microscopically positive resection margin in gastric cancer patients[J]. BMC Surg, 2020, 20(1):95. doi:10.1186/s12893-020-00744-5. |
| [4] | VAN DER WERF L R, CORDS C, ARNTZ I, et al. Population-based study on risk factors for tumor-positive resection margins in patients with gastric cancer[J]. Ann Surg Oncol, 2019, 26(7):2222-2233. doi:10.1245/s10434-019-07381-0. |
| [5] | NICLAUSS N, JUNG M K, CHEVALLAY M, et al. Minimal length of proximal resection margin in adenocarcinoma of the esophagogastric junction:a systematic review of the literature[J]. Updates Surg, 2019, 71(3):401-409. doi:10.1007/s13304-019-00665-w. |
| [6] | FENG F, TIAN Y, XU G, et al. The length of proximal margin does not influence the prognosis of Siewert type Ⅱ/Ⅲ adenocarcinoma of esophagogastric junction after transhiatal curative gastrectomy[J]. Springerplus, 2016,5:588. doi:10.1186/s40064-016-2240-3. |
| [7] | 黄庆峰, 杨立成, 吴建军. 影响Lauren分型胃癌患者行根治术治疗后早期复发的因素分析[J]. 中国中西医结合外科杂志, 2022, 28(3):325-330. |
| HUANG Q F, YANG L C, WU J J. Analysis of factors influencing early recurrence of lauren type gastric cancer after radical resection[J]. Chinese Journal of Integrated Traditional Chinese and Western Medicine Surgery, 2022, 28(3):325-330. doi:10.3969/j.issn.1007-6948.2022.03.008. | |
| [8] | 郭振江, 赵光远, 杜立强, 等. 进展期胃癌脉管侵犯术前列线图预测模型的建立和验证[J]. 天津医药, 2023, 51(12):1382-1386. |
| GUO Z J, ZHAO G Y, DU L Q, et al. Establishment and validation of a predictive nomogram model for advanced gastric cancer with lymphovascular invasion[J]. Tianjin Med J, 2023, 51(12):1382-1386. doi:10.11958/20230513. | |
| [9] | GUO Z, GUO H, TIAN Y, et al. Nomograms for predicting disease-free survival in patients with siewert type II/III adenocarcinoma of the esophagogastric junction receiving neoadjuvant therapy and radical surgery[J]. Front Oncol, 2022, 12:908229. doi:10.3389/fonc.2022.908229. |
| [10] | CHO B C, JEUNG H C, CHOI H J, et al. Prognostic impact of resection margin involvement after extended(D2/D3)gastrectomy for advanced gastric cancer:a 15-year experience at a single institute[J]. J Surg Oncol, 2007, 95(6):461-468. doi:10.1002/jso.20731. |
| [11] | MORGAGNI P, GARCEA D, MARRELLI D, et al. Resection line involvement after gastric cancer surgery:clinical outcome in nonsurgically retreated patients[J]. World J Surg, 2008, 32(12):2661-2667. doi:10.1007/s00268-008-9747-x. |
| [12] | NAGATA T, ICHIKAWA D, KOMATSU S, et al. Prognostic impact of microscopic positive margin in gastric cancer patients[J]. J Surg Oncol, 2011, 104(6):592-597. doi:10.1002/jso.22022. |
| [13] | WOO J W, RYU K W, PARK J Y, et al. Prognostic impact of microscopic tumor involved resection margin in advanced gastric cancer patients after gastric resection[J]. World J Surg, 2014, 38(2):439-446. doi:10.1007/s00268-013-2301-5. |
| [14] | IWATSUKI M, MATSUMOTO C, MIMORI K, et al. The comprehensive review of gastric adenocarcinoma and proximal polyposis of the stomach(GAPPS)from diagnosis and treatment[J]. Ann Gastroenterol Surg, 2023, 7(5):725-732. doi:10.1002/ags3.12708. |
| [15] | Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014(ver. 4)[J]. Gastric Cancer,2017, 20(1):1-19. doi:10.1007/s10120-016-0622-4. |
| [16] | 中华医学会外科学分会腹腔镜与内镜外科学组. Siewert Ⅱ型食管胃结合部腺癌腔镜手术治疗中国专家共识(2023版)[J]. 中华消化外科杂志, 2023, 22(7):799-809. |
| Chinese Society of Laparoscopic and Endoscopic Surgery,Chinese Surgical Society, Chinese Medical Association. Chinese expert consensus on endoscopic surgery for Siewert Ⅱ adenocarcinoma of esophagogastric junction(2023 edition)[J]. Chin J Dig Surg, 2023, 22(7):799-809. doi:10.3760/cma.j.cn115610-20230628-00320. | |
| [17] | MINE S, SANO T, HIKI N, et al. Proximal margin length with transhiatal gastrectomy for Siewert type Ⅱ and III adenocarcinomas of the oesophagogastric junction[J]. Br J Surg, 2013, 100(8):1050-1054. doi:10.1002/bjs.9170. |
| [18] | LEE J H, KIM Y I. Which is the optimal extent of resection in middle third gastric cancer between total gastrectomy and subtotal gastrectomy?[J]. J Gastric Cancer, 2010, 10(4):226-233. doi:10.5230/jgc.2010.10.4.226. |
| [19] | BISSOLATI M, DESIO M, ROSA F, et al. Risk factor analysis for involvement of resection margins in gastric and esophagogastric junction cancer:an Italian multicenter study[J]. Gastric Cancer, 2017, 20(1):70-82. doi:10.1007/s10120-015-0589-6. |
| [20] | GIANDOLA T, MAINO C, MARRAPODI G, et al. Imaging in gastric cancer:current practice and future perspectives[J]. Diagnostics(Basel), 2023, 13(7):1276. doi:10.3390/diagnostics13071276. |
| [21] | WANI A H, PARRY A H, FEROZ I, et al. Preoperative staging of gastric cancer using computed tomography and its correlation with histopathology with emphasis on multi-planar reformations and virtual gastroscopy[J]. J Gastrointest Cancer, 2021, 52(2):606-615. doi:10.1007/s12029-020-00436-6. |
| [22] | JIANG Z Y, KINAMI S, NAKAMURA N, et al. Diagnostic ability of multi-detector spiral computed tomography for pathological lymph node metastasis of advanced gastric cancer[J]. World J Gastrointest Oncol, 2020, 12(4):435-446. doi:10.4251/wjgo.v12.i4.435. |
| [23] | LEE J H, AHN S H, PARK D J, et al. Clinical impact of tumor infiltration at the transected surgical margin during gastric cancer surgery[J]. J Surg Oncol, 2012, 106(6):772-776. doi:10.1002/jso.23123. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||